FLUENCY® PLUS Endovascular Stent Graft for In-stent Restenosis

NACompletedINTERVENTIONAL
Enrollment

275

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

November 30, 2013

Study Completion Date

January 31, 2016

Conditions
Restenosis
Interventions
DEVICE

Fluency Plus Endovascular Stent Graft

Treatment of in-stent restenosis

DEVICE

Percutaneous Transluminal Angioplasty only

Treatment of in-stent restenosis

Trial Locations (23)

11042

ProHEALTH Care Associates LLP, Lake Success

23230

American Access Care of Richmond, Richmond

27610

Capital Access Center, Raleigh

30901

Vascular & Interventional Care Center, Augusta

31404

Savannah Vascular Surgery, Savannah

32216

First Coast Cardiovascular Institute, Jacksonville

35294

University of Alabama Radiology Dept, Birmingham

37919

Premeire Vascular Access and Imaging Center, Knoxsville

44195

Cleveland Clinic Foundation, Cleveland

53215

Midwest Nephrology Associates Vascular Access Center, Milwaukee

53792

University of Wisconsin School of Medicine & Public Health, Madison

60521

MakrisMD, LLC, d/b/a Chicago Access Care, Hinsdale

78215

Renal Associates, P.A. Research Division, San Antonio

85004

Southwest Kidney Institute Inc, Phoenix

85012

Arizona Kidney Disease & Hypertension Center-Surgery Center, Phoenix

85719

Angiocare LLC w/Renal Care Associates PC, Tucson

90706

Greater Long Beach Vascular Access Center, Bellflower

93710

Ladenheim Dialysis Access Centers, Fresno

95815

Capital Nephrology Access Center, Sacramento

06825

American Access Care Connecticut Image Guided Surgery, Fairfield

06510

Yale University, New Haven

01089

The Vascular Access Center, West Springfield

02906

Providence Access Care, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
lead

C. R. Bard

INDUSTRY

NCT01257438 - FLUENCY® PLUS Endovascular Stent Graft for In-stent Restenosis | Biotech Hunter | Biotech Hunter